Eisai Co. Ltd.,  a Japanese pharmaceutical company, has established a holding company Eisai China Holdings Ltd. in Suzhou, Jiangsu Province, China. Eisai China Holdings Ltd. is a subsidiary of Eisai Asia Regional Services Pte. Ltd. which is Eisai’s representative subsidiary for Asia located in Singapore.

With the establishment of this new company,Eisai China Holdings Ltd. will integrate the Chinese domestic subsidiaries Eisai China Inc. and Eisai (Suzhou) Trading Co. Ltd., strengthen various functions including accounting, legal and compliance, and also create a flexible capital transfer system to respond to capital demands,in order to optimise the management of business in China.

The Chinese pharmaceutical market is the second largest in the world after the United States, and is expected to achieve strong double digit growth into the future. Through the establishment of Eisai ChinaHoldings, Eisai plans to further enhance its pharmaceutical production, sales and supply systems in China, and through the stable supply of high quality pharmaceutical products together with the provision of accurate information, strives to fulfill the diverse needs of patients and their families in China.